Inactive Instrument

News Samsara Vision, Inc.

Equities

SMSA

US79600A1051

Summary

Unlock all the news: Be the first to know and act before the market!

Samsara Vision Announces First U.S. Surgeries of the Sing Imt, for Age-Related Macular Degeneration as Part of the Concerto Study	11/07/22	CI
Samsara Vision and Lansheng Medical “Myvision” Announce Collaboration to Commercialize the Sing Imt™ in China	08/06/22	CI
Samsara Vision, Inc. to Initiate A U.S. Pma Supplemental Study of the Sing Imt™, A New-Generation Technology for Age-Related Macular Degeneration	20/04/22	CI
Samsara Vision, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	11/03/22	CI
Samsara Vision, Inc. Auditor Raises 'Going Concern' Doubt	10/03/22	CI
Samsara Vision, Inc. Announces the First Three Successful Clinical Cases in Italy Using Its Sing Imt™	22/02/22	CI
Samsara Vision, Inc. has filed an IPO.	03/11/21	CI
Samsara Vision, Inc. Auditor Raises 'Going Concern' Doubt	30/09/21	CI
VisionCare Ophthalmic Technologies, Inc. Announces Appointment of Thierry Clidiere to Board of Directors	10/03/16	CI
VisionCare Ophthalmic Technologies Announces Executive Appointments	09/09/15	CI
Visioncare Ophthalmic Technologies Announces Executive Changes	15/04/15	CI
VisionCare Ophthalmic Technologies, Inc. announced that it has received funding	15/12/14	CI
VisionCare Ophthalmic Technologies, Inc. Announces Board Changes	15/04/14	CI
VisionCare Ophthalmic Technologies, Inc. Announces Management Promotions	28/03/14	CI
VisionCare Ophthalmic Technologies, Inc. Secures Up to $15 Million to Accelerate Growth of its Novel Treatment for Age-Related Macular Degeneration	17/09/13	CI
VisionCare Ophthalmic Technologies, Inc. announced that it has received $15 million in funding from Life Sciences Alternative Funding LLC.	17/09/13	CI
Visioncare Ophthalmic Technologies, Inc. Receives Health Canada Medical Device License for AMD Treatment	27/11/12	CI
VisionCare Ophthalmic Technologies, Inc. Receives Health Canada License for Telescope Prosthesis for End-Stage Macular Degeneration	08/11/12	CI
Florida Medicare Contractor Covers VisionCare Ophthalmic Technologies, Inc.'s Telescope Implant for End-Stage Macular Degeneration	09/10/12	CI
VisionCare Ophthalmic Technologies, Inc. Expands its CentraSight(TM) Provider Teams Nationwide	08/06/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Samsara Vision, Inc.

Equities

SMSA

US79600A1051

Summary

Filters